Full text
PDFImages in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aksoy M., Erdem S. Aplastic anaemia after propylthiouracil. Lancet. 1968 Jun 22;1(7556):1379–1379. doi: 10.1016/s0140-6736(68)92089-8. [DOI] [PubMed] [Google Scholar]
- Amrhein J. A., Kenny F. M., Ross D. Granulocytopenia, lupus-like syndrome, and other complications of propylthiouracil therapy. J Pediatr. 1970 Jan;76(1):54–63. doi: 10.1016/s0022-3476(70)80130-5. [DOI] [PubMed] [Google Scholar]
- Baker B., Shapiro B., Fig L. M., Woodbury D., Sisson J. C., Beierwaltes W. H. Unusual complications of antithyroid drug therapy: four case reports and review of literature. Thyroidology. 1989 Apr;1(1):17–26. [PubMed] [Google Scholar]
- Bilezikian S. B., Laleli Y., Tsan M. F., Hodkinson B. A., Ice S., McIntyre P. A. Immunological: reactions involving leukocytes: III. Agranulocytosis induced by antithyroid drugs. Johns Hopkins Med J. 1976 Apr;138(4):124–129. [PubMed] [Google Scholar]
- Bloch C. A., Jenski L. J., Balistreri W. F., Dolan L. M. Propylthiouracil-associated hepatitis. Arch Intern Med. 1985 Nov;145(11):2129–2130. [PubMed] [Google Scholar]
- Breese T. J., Solomon I. L. Granulocytopenia and hemolytic anemia as complications of propylthiouracil therapy. J Pediatr. 1975 Jan;86(1):117–119. doi: 10.1016/s0022-3476(75)80721-9. [DOI] [PubMed] [Google Scholar]
- COLWELL A. R., Jr, SANDO D. E., LANG S. J. Propylthiouracil-induced agranulocytosis, toxic hepatitis, and death. J Am Med Assoc. 1952 Feb 23;148(8):639–641. doi: 10.1001/jama.1952.62930080001013. [DOI] [PubMed] [Google Scholar]
- Czaja A. J. Autoimmune hepatitis and viral infection. Gastroenterol Clin North Am. 1994 Sep;23(3):547–566. [PubMed] [Google Scholar]
- EISEN M. J. Fulminant hepatitis during treatment with propylthiouracil. N Engl J Med. 1953 Nov 12;249(20):814–816. doi: 10.1056/NEJM195311122492007. [DOI] [PubMed] [Google Scholar]
- Fedotin M. S., Lefer L. G. Liver disease caused by propylthiouracil. Arch Intern Med. 1975 Feb;135(2):319–321. [PubMed] [Google Scholar]
- Garty B. Z., Kauli R., Ben-Ari J., Lubin E., Nitzan M., Laron Z. Hepatitis associated with propylthiouracil treatment. Drug Intell Clin Pharm. 1985 Oct;19(10):740–742. doi: 10.1177/106002808501901009. [DOI] [PubMed] [Google Scholar]
- Hanson J. S. Propylthiouracil and hepatitis. Two cases and a review of the literature. Arch Intern Med. 1984 May;144(5):994–996. doi: 10.1001/archinte.144.5.994. [DOI] [PubMed] [Google Scholar]
- Hayashida C. Y., Duarte A. J., Sato A. E., Yamashiro-Kanashiro E. H. Neonatal hepatitis and lymphocyte sensitization by placental transfer of propylthiouracil. J Endocrinol Invest. 1990 Dec;13(11):937–941. doi: 10.1007/BF03349663. [DOI] [PubMed] [Google Scholar]
- Jonas M. M., Eidson M. S. Propylthiouracil hepatotoxicity: two pediatric cases and review of the literature. J Pediatr Gastroenterol Nutr. 1988 Sep-Oct;7(5):776–779. [PubMed] [Google Scholar]
- Kirkland J. L. Propylthiouracil-induced hepatic failure and encephalopathy in a child. DICP. 1990 May;24(5):470–471. doi: 10.1177/106002809002400505. [DOI] [PubMed] [Google Scholar]
- Lee W. M. Drug-induced hepatotoxicity. N Engl J Med. 1995 Oct 26;333(17):1118–1127. doi: 10.1056/NEJM199510263331706. [DOI] [PubMed] [Google Scholar]
- Liaw Y. F., Huang M. J., Fan K. D., Li K. L., Wu S. S., Chen T. J. Hepatic injury during propylthiouracil therapy in patients with hyperthyroidism. A cohort study. Ann Intern Med. 1993 Mar 15;118(6):424–428. doi: 10.7326/0003-4819-118-6-199303150-00005. [DOI] [PubMed] [Google Scholar]
- Limaye A., Ruffolo P. R. Propylthiouracil-induced fatal hepatic necrosis. Am J Gastroenterol. 1987 Feb;82(2):152–154. [PubMed] [Google Scholar]
- MOVITT E. R., GERSTL B., DAVIS A. E. Needle liver biopsy in thyrotoxicosis. AMA Arch Intern Med. 1953 Jun;91(6):729–739. doi: 10.1001/archinte.1953.00240180038005. [DOI] [PubMed] [Google Scholar]
- Maddrey W. C., Boitnott J. K. Drug-induced chronic liver disease. Gastroenterology. 1977 Jun;72(6):1348–1353. [PubMed] [Google Scholar]
- Maggiore G., Larizza D., Lorini R., De Giacomo C., Scotta M. S., Severi F. Propylthiouracil hepatotoxicity mimicking autoimmune chronic active hepatitis in a girl. J Pediatr Gastroenterol Nutr. 1989 May;8(4):547–548. doi: 10.1097/00005176-198905000-00025. [DOI] [PubMed] [Google Scholar]
- Mihas A. A., Holley P., Koff R. S., Hirschowitz B. I. Fulminant hepatitis and lymphocyte sensitization due to propylthiouracil. Gastroenterology. 1976 May;70(5 PT1):770–774. [PubMed] [Google Scholar]
- Pacini F., Sridama V., Refetoff S. Multiple complications of propylthiouracil treatment: granulocytopenia, eosinophilia, skin reaction and hepatitis with lymphocyte sensitization. J Endocrinol Invest. 1982 Nov-Dec;5(6):403–407. doi: 10.1007/BF03350541. [DOI] [PubMed] [Google Scholar]
- Parker L. N. Letter: Hepatitis and propylthiouracil. Ann Intern Med. 1975 Feb;82(2):228–229. doi: 10.7326/0003-4819-82-2-228_2. [DOI] [PubMed] [Google Scholar]
- Parker W. A. Propylthiouracil-induced hepatotoxicity. Clin Pharm. 1982 Sep-Oct;1(5):471–474. [PubMed] [Google Scholar]
- Peter S. A. Propylthiouracil-associated hepatitis. J Natl Med Assoc. 1991 Jan;83(1):75–77. [PMC free article] [PubMed] [Google Scholar]
- Reddy C. M. Propylthiouracil and hepatitis: a case report. J Natl Med Assoc. 1979 Dec;71(12):1185–1186. [PMC free article] [PubMed] [Google Scholar]
- Safani M. M., Tatro D. S., Rudd P. Fatal propylthiouracil-induced hepatitis. Arch Intern Med. 1982 Apr;142(4):838–839. [PubMed] [Google Scholar]
- Sammon T. J., Peden V. H., Witzleben C., King J. P. Disseminated intravascular coagulation complicating propylthiouracil therapy. A case description of a 16-year-old girl. Clin Pediatr (Phila) 1971 Dec;10(12):739–742. doi: 10.1177/000992287101001221. [DOI] [PubMed] [Google Scholar]
- Seidman D. S., Livni E., Ilie B., Blum I. Propylthiouracil-induced cholestatic jaundice. J Toxicol Clin Toxicol. 1986;24(4):353–360. doi: 10.3109/15563658608992599. [DOI] [PubMed] [Google Scholar]
- Shiran A., Shechner C., Dickstein G. Propylthiouracil-induced agranulocytosis in four patients previously treated with the drug. JAMA. 1991 Dec 11;266(22):3129–3130. [PubMed] [Google Scholar]
- Vasily D. B., Tyler W. B. Propylthiouracil-induced cutaneous vasculitis. Case presentation and review of the literature. JAMA. 1980 Feb 1;243(5):458–461. doi: 10.1001/jama.243.5.458. [DOI] [PubMed] [Google Scholar]
- Verdy M., Pretty H., Cadotte M., Giroux J. M., Journet M. Vasculite secondaire aux antithyroïdiens. Union Med Can. 1975 Apr;104(4):576–579. [PubMed] [Google Scholar]
- Vitug A. C., Goldman J. M. Hepatotoxicity from antithyroid drugs. Horm Res. 1985;21(4):229–234. doi: 10.1159/000180054. [DOI] [PubMed] [Google Scholar]
- Weiss M., Hassin D., Bank H. Propylthiouracil-induced hepatic damage. Arch Intern Med. 1980 Sep;140(9):1184–1185. [PubMed] [Google Scholar]
- Westphal S. A. Hepatotoxicity from propylthiouracil. South Med J. 1994 Sep;87(9):943–947. doi: 10.1097/00007611-199409000-00018. [DOI] [PubMed] [Google Scholar]